Cortical bone status is associated with serum osteoprotegerin concentration in men: The STRAMBO study

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2216-2226

  Szulc, Pawel ^a   Hawa, G ^b,f   Boutroy, S ^a   Vilayphiou, N ^a   Schoppet, M ^c   Chapurlat, R ^a   Hofbauer, L C ^d,e  

^a UNIVERSITÉ DE LYON   (France)

^b Biomedica   (Austria)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^f Technopolmanager Krems ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; CALCIFEDIOL; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; DEOXYPYRIDINOLINE; ESTRADIOL; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; TESTOSTERONE;

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE STRUCTURE; BONE TURNOVER; CALCIUM INTAKE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICAL BONE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; OSTEOLYSIS; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIUS; TESTOSTERONE BLOOD LEVEL; TIBIA; TRABECULAR BONE;

ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE DENSITY; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PROSPECTIVE STUDIES; TESTOSTERONE;

EID: 79960081858     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2617     Document Type: Article

References (54)

1. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2-12 (Pubitemid 30026926)
2. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C 2009 Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756-765
3. Smith MR, Egerdie B, Hernández Toriz N, Feldman R, Tammela TL, Saad F, Heracek J, Szwedowski M, Ke C, Kupic A, Leder BZ, Goessl C 2009 Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745-755
4. Jørgensen L, Vik A, Emaus N, Brox J, Hansen JB, Mathiesen E, Vestergaard P 2010 Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-κB ligand: the Tromsø Study. Osteoporos Int 21:931-938
5. Stern A, Laughlin GA, Bergstrom J, Barrett-Connor E 2007 The sex-specific association of serum osteoprotegerin and receptor activator of nuclear facto rκB legend with bone mineral density in older adults: the Rancho Bernardo study. Eur J Endocrinol 156:555-562 (Pubitemid 46796522)
6. Indridason OS, Franzson L, Sigurdsson G 2005 Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. Osteoporos Int 16:417-423 (Pubitemid 40487400)
7. Khosla S, Arrighi HM, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL 2002 Correlates of osteoprotegerin levels in women and men. Osteoporos Int 13:394-399 (Pubitemid 34625396)
8. Oh KW, Rhee EJ, Lee WY, Kim SW, Oh ES, Baek KH, Kang MI, Choi MG, Yoo HJ, Park SW 2004 The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women. Clin Endocrinol (Oxf) 61:244-249
9. Rogers A, Saleh G, Hannon RA, Greenfield D, Eastell R 2002 Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab 87:4470-4475 (Pubitemid 35247027)
10. Browner WS, Lui LY, Cummings SR 2001 Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631-637 (Pubitemid 32207471)
11. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y 1999 Immunological characterization of circulating osteoprotegerin/ osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 14:518-527 (Pubitemid 29153384)
12. Oh KW, Rhee EJ, Lee WY, Kim SW, Baek KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, Yoo HJ, Park SW 2005 Circulating osteoprotegerin and receptor activator of NF-κB ligand system are associated with bone metabolism in middle-aged males. Clin Endocrinol (Oxf) 62:92-98 (Pubitemid 40175289)
13. Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD 2001 Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 86:3162-3165 (Pubitemid 32673481)
14. Riggs BL, Melton LJ III, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, Rouleau PA, McCollough CH, Bouxsein ML, Khosla S 2004 Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 19:1945-1954 (Pubitemid 41103408)
15. Paternoster L, Ohlsson C, Sayers A, Vandenput L, Lorentzon M, Evans DM, Tobias JH 2010 OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts. J Clin Endocrinol Metab 95:3940-3948
16. Ohishi M, Chiusaroli R, Ominsky M, Asuncion F, Thomas C, Khatri R, Kostenuik P, Schipani E 2009 Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. Am J Pathol 174:2160-2171
17. Samelson EJ, Broe KE, Demissie S, Beck TJ, Karasik D, Kathiresan S, Kiel DP 2008 Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip. J Clin Endocrinol Metab 93:1789-1795 (Pubitemid 351656519)
18. Szulc P, Delmas PD 2007 Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition. The prospective MINOS study. Osteoporos Int 18:495-503 (Pubitemid 46354917)
19. West SL, Scheid JL, De Souza MJ 2009 The effect of exercise and estrogen on osteoprotegerin in premenopausal women. Bone 44:137-144
20. Daly RM, Bass SL 2006 Lifetime sport and leisure activity participation is associated with greater bone size, quality and strength in older men. Osteoporos Int 17:1258-1267
21. Szulc P, Uusi-Rasi K, Claustrat B, Marchand F, Beck TJ, Delmas PD 2004 Role of sex steroids in the regulation of bone morphology in men. The MINOS study. Osteoporos Int 15:909-917 (Pubitemid 39506458)
22. Szulc P, Claustrat B, Marchand F, Delmas PD 2003 Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. J Clin Endocrinol Metab 88:5240-5247 (Pubitemid 37452722)
23. Khosla S, Melton LJ 3rd, Achenbach SJ, Oberg AL, Riggs BL 2006 Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men. Clin Endocrinol Metab 91:885-891 (Pubitemid 43357754)
24. Benito M, Gomberg B, Wehrli FW, Weening RH, Zemel B, Wright AC, Song HK, Cucchiara A, Snyder PJ 2003 Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab 88:1497-1502 (Pubitemid 36623360)
25. Gannagé-Yared MH, Fares F, Semaan M, Khalife S, Jambart S 2006 Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. Clin Endocrinol (Oxf) 64:652-658 (Pubitemid 43775003)
26. Bacchetta J, Boutroy S, Vilayphiou N, Juillard L, Guebre-Egziabher F, Rognant N, Sornay-Rendu E, Szulc P, Laville M, Delmas PD, Fouque D, Chapurlat R 2010 Early impairment of trabecular microarchitecture assessed with HR-pQCTin patients with stage II-IV chronic kidney disease. J Bone Miner Res 25:849-857
27. Kazama JJ, Shigematsu T, Yano K, Tsuda E, Miura M, Iwasaki Y, Kawaguchi Y, Gejyo F, Kurokawa K, Fukagawa M 2002 Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 39:525-532 (Pubitemid 34194628)
28. Nakchbandi IA, Lang R, Kinder B, Insogna KL 2008 The role of the receptor activator of nuclear factor-κB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism. J Clin Endocrinol Metab 93:967-973 (Pubitemid 351398581)
29. Chaitou A, Boutroy S, Vilayphiou N, Munoz F, Delmas PD, Chapurlat R, Szulc P 2010 Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study. J Bone Miner Res 25:2313-2323
30. Bremond AG, Claustrat B, Rudigoz RC, Seffert P, Corniau J 1982 Estradiol, androstenedione, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer. Gynecol Oncol 14:119-124 (Pubitemid 12055341)
31. Szulc P, Claustrat B, Munoz F, Marchand F, Delmas PD 2004 Assessment of the role of 17β-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study. Clin Endocrinol (Oxf) 61:447-457 (Pubitemid 39388483)
32. Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD 2003 Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study. Calcif Tissue Int 73:520-530 (Pubitemid 37517796)
33. Boutroy S, Bouxsein ML, Munoz F, Delmas PD 2005 In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90:6508-6515
34. Fardellone P, Sebert JL, Bouraya M, Bonidan O, Leclercq G, Doutrellot C, Bellony R, Dubreuil A 1991 Evaluation de la teneur en calcium du re'gime alimentaire par autoquestionnaire fre'quentiel. Rev Rhum 58:99-103
35. Ueland T, Brixen K, Mosekilde L, Mosekilde L, Flyvbjerg A, Bollerslev J 2003 Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. J Clin Endocrinol Metab 88:1014-1018 (Pubitemid 36337749)
36. Ueland T, Odgren PR, Yndestad A, Godang K, Schreiner T, Marks SC, Bollerslev J 2003 Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency-relationship with bone turn-over. Bone 33:638-645 (Pubitemid 37222390)
37. Tang L, Lin Z, Li YM 2006 Effects of different magnitudes of mechanical strain on osteoblasts in vitro. Biochem Biophys Res Commun 344:122-128
38. Scott JP, Sale C, Greeves JP, Casey A, Dutton J, Fraser WD 2010 The effect of training status on the metabolic response of bone to an acute bout of exhaustive treadmill running. J Clin Endocrinol Metab 95:3918-3925
39. Szulc P, Boutroy S, Vilayphiou N, Chaitou A, Delmas PD, Chapurlat R 16 December 2010 Cross-sectional analysis of the association between fragility fractures and bone microarchitecture in older men: the STRAMBO study. J Bone Miner Res 10.1002/jbmr.319
40. Dobnig H, Piswanger-Sölkner JC, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Riedmüller G, Brueck C, Fahrleitner-Pammer A 2007 Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements. J Clin Endocrinol Metab 92:1678-1686 (Pubitemid 46997171)
41. Schett G, Kiechl S, Redlich K, Oberhollenzer F, Weger S, Egger G, Mayr A, Jocher J, Xu Q, Pietschmann P, Teitelbaum S, Smolen J, Willeit J 2004 Soluble RANKL and risk of nontraumatic fracture. JAMA 291:1108-1113 (Pubitemid 38541688)
42. Grundt A, Grafe IA, Liegibel U, Sommer U, Nawroth P, Kasperk C 2009 Direct effects of osteoprotegerin on human bone cell metabolism. Biochem Biophys Res Commun 389:550-555
43. Smith BB, Cosenza ME, Mancini A, Dunstan C, Gregson R, Martin SW, Smith SY, Davis H 2003 A toxicity profile of osteoprotegerin in the cynomolgus monkey. Int J Toxicol 22:403-412 (Pubitemid 37377085)
44. Ross AB, Bateman TA, Kostenuik PJ, Ferguson VL, Lacey DL, Dunstan CR, Simske SJ 2001 The effects of osteoprotegerin on the mechanical properties of rat bone. J Mater Sci Mater Med 12:583-588 (Pubitemid 32682113)
45. Ominsky MS, Stolina M, Li X, Corbin TJ, Asuncion FJ, Barrero M, Niu QT, Dwyer D, Adamu S, Warmington KS, Grisanti M, Tan HL, Ke HZ, Simonet WS, Kostenuik PJ 2009 One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength. J Bone Miner Res 24:1234-1246
46. Seeman E 2003 Periosteal bone formation: a neglected determinant of bone strength. N Engl J Med 349:320-323 (Pubitemid 36886235)
47. Tommasini SM, Nasser P, Schaffler MB, Jepsen KJ 2005 Relationship between bone morphology and bone quality in male tibias: implications for stress fracture risk. J Bone Miner Res 20:1372-1380 (Pubitemid 41033522)
48. Szulc P, Seeman E 2009 Thinking inside and outside the envelopes of bone: dedicated to PDD. Osteoporos Int 20:1281-1288
49. Szulc P, Munoz F, Duboeuf F, Marchand F, Delmas PD 2006 Low width of tubular bones is associated with increased risk of fragility fracture in elderly men: the MINOS study. Bone 38:595-602
50. Szulc P 2006 Bone density, geometry, and fracture in elderly men. Curr Osteoporos Rep 4:57-63 (Pubitemid 44623937)
51. Defino HL, da Silva Herrero CF, Crippa GE, Bellesini LS, Beloti MM, Rosa AL 2009 In vitro proliferation and osteoblastic phenotype expression of cells derived from human vertebral lamina and iliac crest. Spine 34:1549-1553
52. Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel LJ, HoletsM, Peterson JM, Malton 3rd LJ 2006 Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res 21:124-131 (Pubitemid 43023234)
53. Joseph F, Chan BY, Durham BH, Ahmad AM, Vinjamuri S, Gallagher JA, Vora JP, Fraser WD 2007 The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion. J Clin Endocrinol Metab 92:3230-3238 (Pubitemid 47236397)
54. Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S 2010 Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res 25:983-993